Search academic texts

Information × Registration Number 0200U001449, 0197U013432 , R & D reports Title Determination of Clinico-hematological Compensation Markers in Patients with Hemoblastosis in the Presence of Retinol Therapeutic Doses in Complex Therapy Schemes popup.stage_title Head Isakova Lyudmyla Mykhajlivna, Registration Date 18-02-2000 Organization Kiev Research Institute of Haematolojy and Blood Transfusion popup.description2 Retinol level values in patients with different myeloid leukemia variants in different disease and therapy stages are shown not to differ much one from another and to be reliably lower than norma, except the analogous values in the patients under remission. Vitamin A adding to the programme polychemotherapy (PCT) decreases intoxication syndrome, promotes wound healing, organism antioxidant protection system strengthening, lessens lipoperoxidase molecular product content, promotes the normalizing of cell membrane functional peculiarities. Renovation of bone marrow (BM) structural-functional units, in particular, of erythropoiesis islands, is referred to the main markers of clinico-hematological compensation while retinol-therapy conducting. Product Description popup.authors popup.nrat_date 2020-04-03 Close